Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14).
Nguyen N, Chaudhry S, Totiger TM, Diaz R, Roberts E, Montoya S, Pardo G, Pardo A, Afaghani J, Affer M, Jahn J, Bradley T, Maura F, Kazandjian D, Bilbao D, Chapman J, Landgren O, Hoffman J, Taylor J. Nguyen N, et al. Among authors: pardo g, pardo a. NPJ Precis Oncol. 2022 Oct 19;6(1):73. doi: 10.1038/s41698-022-00315-2. NPJ Precis Oncol. 2022. PMID: 36261486 Free PMC article.
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.
Montoya S, Bourcier J, Noviski M, Lu H, Thompson MC, Chirino A, Jahn J, Sondhi AK, Gajewski S, Tan YSM, Yung S, Urban A, Wang E, Han C, Mi X, Kim WJ, Sievers Q, Auger P, Bousquet H, Brathaban N, Bravo B, Gessner M, Guiducci C, Iuliano JN, Kane T, Mukerji R, Reddy PJ, Powers J, Sanchez Garcia de Los Rios M, Ye J, Barrientos Risso C, Tsai D, Pardo G, Notti RQ, Pardo A, Affer M, Nawaratne V, Totiger TM, Pena-Velasquez C, Rhodes JM, Zelenetz AD, Alencar A, Roeker LE, Mehta S, Garippa R, Linley A, Soni RK, Skånland SS, Brown RJ, Mato AR, Hansen GM, Abdel-Wahab O, Taylor J. Montoya S, et al. Among authors: pardo g, pardo a. Science. 2024 Feb 2;383(6682):eadi5798. doi: 10.1126/science.adi5798. Epub 2024 Feb 2. Science. 2024. PMID: 38301010 Free PMC article.
Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS: Nine-Year Data From the OPERA Studies Open-Label Extension.
Cerqueira JJ, Berthele A, Cree BAC, Filippi M, Pardo G, Pearson OR, Traboulsee A, Ziemssen T, Vollmer T, Bernasconi C, Mandel CR, Kulyk I, Chognot C, Raposo C, Schneble HM, Thanei GA, Incera E, Havrdová EK. Cerqueira JJ, et al. Among authors: pardo g. Neurology. 2025 Feb 25;104(4):e210142. doi: 10.1212/WNL.0000000000210142. Epub 2025 Jan 30. Neurology. 2025. PMID: 39883906 Free PMC article. Clinical Trial.
The pace of life for forest trees.
Bialic-Murphy L, McElderry RM, Esquivel-Muelbert A, van den Hoogen J, Zuidema PA, Phillips OL, de Oliveira EA, Loayza PA, Alvarez-Davila E, Alves LF, Maia VA, Vieira SA, Arantes da Silva LC, Araujo-Murakami A, Arets E, Astigarraga J, Baccaro F, Baker T, Banki O, Barroso J, Blanc L, Bonal D, Bongers F, Bordin KM, Brienen R, de Medeiros MB, Camargo JL, Araújo FC, Castilho CV, Castro W, Moscoso VC, Comiskey J, Costa F, Müller SC, de Almeida EC, Lôla da Costa AC, de Andrade Kamimura V, de Oliveira F, Del Aguila Pasquel J, Derroire G, Dexter K, Di Fiore A, Duchesne L, Emílio T, Farrapo CL, Fauset S, Draper FC, Feldpausch TR, Ramos RF, Martins VF, Simon MF, Reis MG, Manzatto AG, Herault B, Herrera R, Coronado EH, Howe R, Huamantupa-Chuquimaco I, Huasco WH, Zanini KJ, Joly C, Killeen T, Klipel J, Laurance SG, Laurance WF, Fontes MAL, Oviedo WL, Magnusson WE, Dos Santos RM, Peña JLM, de Abreu KMP, Marimon B, Junior BHM, Melgaço K, Melo Cruz OA, Mendoza C, Monteagudo-Mendoza A, Morandi PS, Gianasi FM, Nascimento H, Nascimento M, Neill D, Palacios W, Camacho NCP, Pardo G, Pennington RT, Peñuela-Mora MC, Pitman NCA, Poorter L, Cruz AP, Ramírez-Angulo H, Reis SM, Correa ZR, Rodriguez C… See abstract for full author list ➔ Bialic-Murphy L, et al. Among authors: pardo g. Science. 2024 Oct 4;386(6717):92-98. doi: 10.1126/science.adk9616. Epub 2024 Oct 3. Science. 2024. PMID: 39361744 Free article.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
Obesity intensifies sex-specific interferon signaling to selectively worsen central nervous system autoimmunity in females.
Cordeiro B, Ahn JJ, Gawde S, Ucciferri C, Alvarez-Sanchez N, Revelo XS, Stickle N, Massey K, Brooks DG, Guthridge JM, Pardo G, Winer DA, Axtell RC, Dunn SE. Cordeiro B, et al. Among authors: pardo g. Cell Metab. 2024 Oct 1;36(10):2298-2314.e11. doi: 10.1016/j.cmet.2024.07.017. Epub 2024 Aug 20. Cell Metab. 2024. PMID: 39168127 Free article.
166 results